dna repair and prostate cancer
DESCRIPTION
Special Project presentation at George Washington University, 2003TRANSCRIPT
Genetic Variants of DNA Repair genes and Prostate Cancer:
Department of Epidemiology and Biostatistics
George Washington University
July 2003
A Population-Based Case-Control Study in China
Jamie D. Ritchey
Prostate Cancer • The prostate, anatomical location• International patterns• Etiology• Genetic susceptibility, SNPs, and DNA repair• The Shanghai Prostate Cancer Study• Objectives• Methods: genotyping, statistical analysis• Results• Strengths and limitations• Conclusions• Future Research• Questions
The Male urinary and reproductive system
International Patterns
Hsing, Tsao, and Devesa, International Journal of Cancer, 2000.
African American men
Chinese men in China
Etiology: Risk factors for prostate cancer
Known risk factors:• Age• Race• Family history
Probable Risk factors: • Diet, obesity (BMI, WHR,
IR), leptin, physical activity
• Diabetes, IGF-1, insulin• Androgens• Sexual behavior/sexually
transmitted disease, vasectomy
• Smoking• Alcohol• Liver cirrhosis• Low-penetrant Genetic
component?ACS, www.acs.gov 2003 NCI, www.nci.gov 2003
Genetic susceptibility to cancer
High penetrant genes1
• Rare in the population• Almost always cause
cancer in the individual• Examples:HPC1,
HPC2/ELAC2, HPCX, HPC20, PCAP, CAPB, BRCA1 and BRCA2
Low penetrant genes2
• More common in population, may be a larger risk factor
• Do not always cause cancer in the individual
• Different Single nucleotide polymorphisms (SNPs) of the same marker may increase or decrease cancer risk
• Hormone: AR, SRD5A2, ER, etc.
• DNA repair genes: XRCC1, XRCC3, XRCC5, ERCC1, ERCC2, MGMT, hOGG1, POLB
1Stanford, Epidemiologic Reviews, 2001. 2Greenhut, Kerrigan, and Kelly, http://press2.nci.nih.gov/sciencebehind/snps_cancer/snps_cancer/snps_ , 2003.
Single Nucleotide Polymorphisms (SNPs)
Greenhut, Kerrigan, and Kelly, http://press2.nci.nih.gov/sciencebehind/snps_cancer/snps_cancer/snps_ , 2003.
Change in shape Altered Cancer Risk
SNP: Decreased DNA repair
capacity
Genomic instability
Oncogene activationInactivate Tumor suppressors
Loss of heterozygosity
DNA repair
• Base Excision Repair (BER)1,3
• Direct Damage Reversal1
• Nucleotide Excision Repair (NER)1
• Non-homologous end-joining and Homologous recombination repair (NHEJ and HR)1,3
• Mismatch Repair (MMR)1,2
XRCC1_399
MGMT_84 and MGMT_143
ERCC2_751
XRCC3_241 (specifically in HR)
2No markers in study, ex: MSH2, MLH1, MSH6, PMS2,
PMS1, hOGG1
Pathway Marker
1Poirier, 2002 2Chen, 2001 3Goode, 2002
DNA Repair Pathways
• Reversal of alkyl group(-CH2-CH3, and -CH3)
• DNA Replication or Recombination
• Bulky AdductUV-induced Damage
• Reactive Oxygen, Restriction Enzymes, and Normal Cell Process
Non-Bulky Adduct, Oxidative Stress, and Ionizing Radiation
Environmental Factors(Diet)
+SNP of DNA repair genes
= latent effects increasing
prostate cancer risk ?
Greenhut, Kerrigan, and Kelly,http://press2.nci.nih.gov/sciencebehind/snps_cancer/snps_cancer/snps_ , 2003.
Shanghai Prostate Cancer Study
A Population-Based Case control Study(Cases collected from: 1993-1995)
Study components included:
• In-person interview• Medical record abstraction• Anthropometric measurements• Collection of fasting blood
Objectives
• The primary objective: to investigate whether five different DNA repair markers, specifically: XRCC1_399, XRCC3_241, ERCC2_751, MGMT_84 and MGMT_143 play a role in the etiology of prostate cancer.
• Secondary objectives included: the risk of prostate cancer and the five DNA repair markers by the probable risk factors:
-Waist to hip ratio, WHR -Insulin resistance, IR -Diet
Shanghai Prostate Cancer Study Study Design
268 Prostate cancer cases
Interview
200 cases provided 20 ml fasting blood
330 controls provided 20 ml of fasting blood
191 Cases Genotyped
305 controlsGenotyped
495 Population Controls
243 cases interviewed
472 controls interviewed
Genotyping Blood
Buffy coat
Purified DNA
MALDI-TOF/hME assaysXRCC1_399, XRCC3_241, ERCC2_751, MGMT_84, MGMT_143
191 Cases Genotyped
305 controlsGenotyped
Statistical Analysis
Logistic regression was used to calculate the ORs and the 95% CIs to investigate marker main effects and markers by other potential risk factors
RESULTS
Selected demographic characteristicsCharacteristic Cases (n=162) Controls (n=251)
N
61
50
51
%
15
12
12
N
78
89
84
%
19
22
20
14
124
24
0
9
76
15
0
29
191
30
1
12
76
12
~1
61
50
48
2
38
31
30
1
-
-
-
-
-
-
-
-
Age<69
70-75>76
EducationNone
Elementary-high
College/ above
OtherStage
LocalizedRegionalRemote
Unknown/unstaged
PSA
G e n e t ic M a r k e r s M a in E f f e c t s
1 0 .8 3
2 .1 8
G G A G A A
A d ju s te d fo r a g e
1
1 .95
3 .39
CC CT TT
10 .8 4
2 .2 3
C C C T T T
1
1 .5 5
A A A G G G
N /A
X R C C 1 _ 3 9 9 M G M T _ 8 4
X R C C 3 _ 2 4 1
E R C C 2 _ 7 5 1
M G M T _ 1 4 3
1
0 .8 7
A A A C C C
N /A
Genetic Markers and other Factors: Combined Effects
XRCC1_399
1.89 1.96
3.02
10.53
3.21
GG AG AA
<0.097
>=0.097
2.29 2.02
3.19
10.79
3.85
GG AG AA
<0.892
>=0.892
Waist to Hip Ratio
InsulinResistance
Age-Adjusted
Genetic Markers and other Factors: Combined Effects
MGMT_84
1.05
4.76
11.92
CC CT+TT
<0.892
>=0.892
1.99
6.37
1 0.95
CC CT+TT
<0.097
>=0.097
Waist to hip Ratio
Insulin Resistance
Age-Adjusted
Genetic Markers and other Factors: Combined Effects
XRCC1_399 Total Preserved Food
1.791.48
1 1.08
GG AG+AA
<12.7
>=12.7
Age-adjusted
Genetic Markers and other Factors: Combined Effects
MGMT_84 Total Preserved Food
1.66
2.81
1
2.31
CC CT+TT
<12.7
>=12.7
Genetic Markers and other Factors: Combined Effects
XRCC1_399Allium Vegetable intake
1 1.08
0.530.39
GG AG+AA
>=5.83
<5.83
Genetic Markers and other Factors: Combined Effects
MGMT_84Allium Vegetable intake
1
2.34
0.54 0.63
CC CT+TT
>=5.83
<5.83
Study strengths
• Population-based
• High response rates
• Nearly compete case ascertainment
• Pathology review
• In-person interviews
• High accuracy of Laboratory results
Study limitations
• Small Sample size
• Generalizability
Conclusions• XRCC1_399 AA and the MGMT_84 CT/TT
may increase prostate cancer risk
• DNA repair capacity of both markers may be effected by: abdominal obesity, insulin resistance, preserved food consumption and allium vegetables
• No association was seen with alleles of XRCC3_241, ERCC2_241 and MGMT_143, but these may still increase or decrease cancer risk
Future Research
• Larger Studies
-- Accrue greater number of cases
-- Enroll larger set of controls
• Confirmation in Western populations
• Additional markers investigated in each
pathway
AcknowledgementsNational Cancer Institute
Shanghai Cancer Institute
Shanghai Tumor Hospital
George Washington University
Ann Hsing, Ph.D.
Joseph Fraumeni, Jr., M.D.
Gloria Gridley, M.S.
Yu-Tang Gao, M.D.
Jie Deng, M.D.
Ming-Chang Shen, M.D.
Paul Levine, M.D.